| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials.
|
J Gerontol A Biol Sci Med Sci
|
2005
|
3.14
|
|
2
|
Testosterone administration to older men improves muscle function: molecular and physiological mechanisms.
|
Am J Physiol Endocrinol Metab
|
2002
|
2.24
|
|
3
|
Management of blood glucose in type 2 diabetes mellitus.
|
Am Fam Physician
|
2009
|
2.09
|
|
4
|
Trends in androgen prescribing in the United States, 2001 to 2011.
|
JAMA Intern Med
|
2013
|
2.05
|
|
5
|
Novel noninvasive breath test method for screening individuals at risk for diabetes.
|
Diabetes Care
|
2008
|
1.57
|
|
6
|
Amino acid supplementation increases lean body mass, basal muscle protein synthesis, and insulin-like growth factor-I expression in older women.
|
J Clin Endocrinol Metab
|
2009
|
1.45
|
|
7
|
Essential amino acid and carbohydrate supplementation ameliorates muscle protein loss in humans during 28 days bedrest.
|
J Clin Endocrinol Metab
|
2004
|
1.43
|
|
8
|
Differential anabolic effects of testosterone and amino acid feeding in older men.
|
J Clin Endocrinol Metab
|
2003
|
1.16
|
|
9
|
Single and combined effects of growth hormone and testosterone administration on measures of body composition, physical performance, mood, sexual function, bone turnover, and muscle gene expression in healthy older men.
|
J Clin Endocrinol Metab
|
2002
|
1.13
|
|
10
|
The role of androgens and estrogens on healthy aging and longevity.
|
J Gerontol A Biol Sci Med Sci
|
2012
|
1.13
|
|
11
|
Effect of growth hormone replacement therapy on cognition after traumatic brain injury.
|
J Neurotrauma
|
2010
|
1.08
|
|
12
|
An overview of the endocrinology of skeletal muscle.
|
Trends Endocrinol Metab
|
2004
|
1.02
|
|
13
|
The catabolic effects of prolonged inactivity and acute hypercortisolemia are offset by dietary supplementation.
|
J Clin Endocrinol Metab
|
2004
|
1.01
|
|
14
|
Amino acid metabolism and inflammatory burden in ovarian cancer patients undergoing intense oncological therapy.
|
Clin Nutr
|
2007
|
0.98
|
|
15
|
Androgen therapy induces muscle protein anabolism in older women.
|
J Clin Endocrinol Metab
|
2006
|
0.94
|
|
16
|
Pathogenesis of muscle wasting in cancer cachexia: targeted anabolic and anticatabolic therapies.
|
Curr Opin Clin Nutr Metab Care
|
2010
|
0.89
|
|
17
|
Identification of ERK and JNK as signaling mediators on protein kinase C activation in cultured granulosa cells.
|
Mol Cell Endocrinol
|
2008
|
0.88
|
|
18
|
A randomized pilot study of monthly cycled testosterone replacement or continuous testosterone replacement versus placebo in older men.
|
J Clin Endocrinol Metab
|
2011
|
0.87
|
|
19
|
Identification of serum biomarkers for aging and anabolic response.
|
Immun Ageing
|
2011
|
0.86
|
|
20
|
Muscle protein metabolism responds similarly to exogenous amino acids in healthy younger and older adults during NO-induced hyperemia.
|
Am J Physiol Regul Integr Comp Physiol
|
2011
|
0.85
|
|
21
|
Hormone treatment and muscle anabolism during aging: androgens.
|
Clin Nutr
|
2010
|
0.83
|
|
22
|
The use of DNA microarrays to assess clinical samples: the transition from bedside to bench to bedside.
|
Recent Prog Horm Res
|
2003
|
0.82
|
|
23
|
IGF-1 controls GLUT3 expression in muscle via the transcriptional factor Sp1.
|
Biochim Biophys Acta
|
2007
|
0.82
|
|
24
|
Effects of raloxifene on insulin sensitivity, beta-cell function, and hepatic insulin extraction in normal postmenopausal women.
|
Fertil Steril
|
2007
|
0.82
|
|
25
|
Cancer cachexia and anabolic interventions: a case report.
|
J Cachexia Sarcopenia Muscle
|
2012
|
0.80
|
|
26
|
Effect of recombinant growth hormone replacement in a growth hormone deficient subject recovering from mild traumatic brain injury: A case report.
|
Brain Inj
|
2010
|
0.80
|
|
27
|
Up-regulation of basal transcriptional activity of the cytochrome P450 cholesterol side-chain cleavage (CYP11A) gene by isoform-specific calcium-calmodulin-dependent protein kinase in primary cultures of ovarian granulosa cells.
|
Endocrinology
|
2004
|
0.79
|
|
28
|
Aerobic capacity and growth hormone deficiency after traumatic brain injury.
|
J Clin Endocrinol Metab
|
2008
|
0.79
|
|
29
|
Insulin-like growth factor-I activates extracellularly regulated kinase to regulate the p450 side-chain cleavage insulin-like response element in granulosa cells.
|
Endocrinology
|
2010
|
0.78
|
|
30
|
Serum IGF-1 concentrations in a sample of patients with traumatic brain injury as a diagnostic marker of growth hormone secretory response to glucagon stimulation testing.
|
Clin Endocrinol (Oxf)
|
2011
|
0.78
|
|
31
|
What are critical outcome measures for patients receiving pituitary replacement following brain injury?
|
Pituitary
|
2012
|
0.78
|
|
32
|
Sex steroid receptors in skeletal differentiation and epithelial neoplasia: is tissue-specific intervention possible?
|
Bioessays
|
2009
|
0.77
|
|
33
|
Hormonal replacement in patients with brain injury-induced hypopituitarism: who, when and how to treat?
|
Pituitary
|
2005
|
0.76
|
|
34
|
Expression of messenger ribonucleic acid encoding steroidogenic enzymes in postmenopausal ovaries.
|
J Soc Gynecol Investig
|
2003
|
0.76
|
|
35
|
The relationships between testosterone, body composition, and insulin resistance: a lesson from a case of extreme hyperandrogenism.
|
Diabetes Care
|
2005
|
0.75
|
|
36
|
Weekly versus monthly testosterone administration on fast and slow skeletal muscle fibers in older adult males.
|
J Clin Endocrinol Metab
|
2014
|
0.75
|
|
37
|
Critical issues for engineering cord blood stem cells to produce insulin.
|
Expert Opin Biol Ther
|
2008
|
0.75
|